Mechanism and evolutionary origins of alanine-tail C-degron recognition by E3 ligases Pirh2 and CRL2-KLHDC10.

Ala-tail C-end degron CP: Molecular biology E3 ubiquitin ligase KLHDC10 Pirh2 polyalanine protein degradation protein quality control protein-protein interaction structure prediction

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
26 09 2023
Historique:
received: 20 03 2023
revised: 11 07 2023
accepted: 22 08 2023
medline: 5 10 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

In ribosome-associated quality control (RQC), nascent polypeptides produced by interrupted translation are modified with C-terminal polyalanine tails ("Ala-tails") that function outside ribosomes to induce ubiquitylation by E3 ligases Pirh2 (p53-induced RING-H2 domain-containing) or CRL2 (Cullin-2 RING ligase2)-KLHDC10. Here, we investigate the molecular basis of Ala-tail function using biochemical and in silico approaches. We show that Pirh2 and KLHDC10 directly bind to Ala-tails and that structural predictions identify candidate Ala-tail-binding sites, which we experimentally validate. The degron-binding pockets and specific pocket residues implicated in Ala-tail recognition are conserved among Pirh2 and KLHDC10 homologs, suggesting that an important function of these ligases across eukaryotes is in targeting Ala-tailed substrates. Moreover, we establish that the two Ala-tail-binding pockets have convergently evolved, either from an ancient module of bacterial provenance (Pirh2) or via tinkering of a widespread C-degron-recognition element (KLHDC10). These results shed light on the recognition of a simple degron sequence and the evolution of Ala-tail proteolytic signaling.

Identifiants

pubmed: 37676773
pii: S2211-1247(23)01111-7
doi: 10.1016/j.celrep.2023.113100
pmc: PMC10591846
mid: NIHMS1933911
pii:
doi:

Substances chimiques

Alanine OF5P57N2ZX
RCHY1 protein, human EC 2.3.2.27
Ubiquitin-Protein Ligases EC 2.3.2.27
Carrier Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113100

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS102414
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Annu Rev Cell Dev Biol. 2017 Oct 6;33:439-465
pubmed: 28992440
Nat Struct Mol Biol. 2008 Dec;15(12):1334-42
pubmed: 19043414
J Biol Chem. 2008 Mar 21;283(12):8005-13
pubmed: 18187417
Cell. 2003 Mar 21;112(6):779-91
pubmed: 12654245
Sci Rep. 2016 Sep 27;6:33964
pubmed: 27670777
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
PLoS Genet. 2011 Nov;7(11):e1002360
pubmed: 22125490
Sci Rep. 2018 Apr 18;8(1):6196
pubmed: 29670199
Biochem Soc Trans. 2020 Aug 28;48(4):1557-1567
pubmed: 32627813
Bioinformatics. 2019 Aug 15;35(16):2856-2858
pubmed: 30615063
Mol Cancer Res. 2011 Dec;9(12):1780-90
pubmed: 21994467
Nat Chem Biol. 2022 Nov;18(11):1214-1223
pubmed: 35982226
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Rev Mol Cell Biol. 2019 Jun;20(6):368-383
pubmed: 30940912
Nat Chem Biol. 2019 Aug;15(8):786-794
pubmed: 31320752
J Invest Dermatol. 2013 May;133(5):1178-87
pubmed: 23235527
Cell. 2012 Nov 21;151(5):1042-54
pubmed: 23178123
Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):358-366
pubmed: 30622213
EMBO J. 2021 Apr 1;40(7):e105846
pubmed: 33469951
Mol Biosyst. 2011 Jul;7(7):2261-77
pubmed: 21547297
EMBO Rep. 2008 Nov;9(11):1107-13
pubmed: 18787558
Nat Methods. 2022 Jun;19(6):679-682
pubmed: 35637307
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W244-8
pubmed: 15980461
Sci Rep. 2019 May 16;9(1):7481
pubmed: 31097749
Cell. 2019 Jun 27;178(1):76-90.e22
pubmed: 31155236
Mol Cell. 2022 Apr 21;82(8):1424-1438
pubmed: 35247307
iScience. 2020 Mar 27;23(3):100970
pubmed: 32200094
Nat Commun. 2022 Jan 10;13(1):176
pubmed: 35013344
Science. 2021 Dec 10;374(6573):eabm4805
pubmed: 34762488
Mol Cell. 2021 May 20;81(10):2112-2122.e7
pubmed: 33909987
Trends Biochem Sci. 1998 Nov;23(11):444-7
pubmed: 9852764
Mol Cell. 2023 Mar 2;83(5):770-786.e9
pubmed: 36805027
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Mol Cell. 2012 Dec 14;48(5):692-704
pubmed: 23102700
Science. 2015 Jan 2;347(6217):75-8
pubmed: 25554787
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
PLoS One. 2016 Sep 15;11(9):e0163118
pubmed: 27631783
Annu Rev Biochem. 2009;78:399-434
pubmed: 19489725
Exp Biol Med (Maywood). 2017 Jun;242(11):1150-1157
pubmed: 28485685
Annu Rev Biochem. 2017 Jun 20;86:129-157
pubmed: 28375744
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2203218119
pubmed: 35867826
Nat Chem Biol. 2021 Mar;17(3):254-262
pubmed: 33398168
Nature. 2010 Sep 23;467(7314):470-3
pubmed: 20835226
Nat Chem Biol. 2021 Mar;17(3):263-271
pubmed: 33398170
Annu Rev Biochem. 2007;76:101-24
pubmed: 17291191
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
EMBO J. 2000 Jun 15;19(12):3016-27
pubmed: 10856245
Cell. 2018 Jun 14;173(7):1622-1635.e14
pubmed: 29779948
Nature. 2022 Mar;603(7901):509-514
pubmed: 35264791
Nucleic Acids Res. 2021 Jul 2;49(W1):W431-W437
pubmed: 33956157
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Elife. 2017 Jul 18;6:
pubmed: 28718767
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Science. 2017 Jul 28;357(6349):414-417
pubmed: 28751611
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Mol Cell. 2018 Dec 6;72(5):813-822.e4
pubmed: 30526872
Nat Med. 2000 Oct;6(10):1073-81
pubmed: 11017125
Nature. 2022 Oct;610(7933):775-782
pubmed: 36261529
Cell Rep. 2021 Jan 5;34(1):108599
pubmed: 33406423
Elife. 2016 Mar 04;5:e11794
pubmed: 26943317
Mol Cell. 2018 May 17;70(4):602-613.e3
pubmed: 29775578
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
Cell Div. 2008 Feb 18;3:7
pubmed: 18282298

Auteurs

Pratik Rajendra Patil (PR)

Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH-Alliance, 69120 Heidelberg, Germany.

A Maxwell Burroughs (AM)

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.

Mohit Misra (M)

Institute of Biochemistry II, Goethe University Faculty of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Strasse 15, 60438 Frankfurt am Main, Germany.

Federico Cerullo (F)

Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH-Alliance, 69120 Heidelberg, Germany.

Carlos Costas-Insua (C)

Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH-Alliance, 69120 Heidelberg, Germany.

Hao-Chih Hung (HC)

Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH-Alliance, 69120 Heidelberg, Germany.

Ivan Dikic (I)

Institute of Biochemistry II, Goethe University Faculty of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany; Buchmann Institute for Molecular Life Sciences, Goethe University Frankfurt, Max-von-Laue-Strasse 15, 60438 Frankfurt am Main, Germany.

L Aravind (L)

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.

Claudio A P Joazeiro (CAP)

Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH-Alliance, 69120 Heidelberg, Germany; Department of Molecular Medicine, UF Scripps Biomedical Research, Jupiter, FL 33458, USA. Electronic address: c.joazeiro@zmbh.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH